Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 9703729, 23 pages
http://dx.doi.org/10.1155/2016/9703729
Review Article

The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes—The Lorenz E. Zimmerman Tribute Lecture

1Departments of Ophthalmology and Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA 17033, USA
2Department of Neural and Behavioral Sciences, The Penn State University College of Medicine, Hershey, PA 17033, USA

Received 6 April 2016; Accepted 24 April 2016

Academic Editor: Nikolaos Papanas

Copyright © 2016 Joseph W. Sassani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. S. Zagon, J. W. Sassani, and P. J. McLaughlin, “Reepithelialization of the human cornea is regulated by endogenous opioids,” Investigative Ophthalmology & Visual Science, vol. 41, no. 1, pp. 73–81, 2000. View at Google Scholar · View at Scopus
  2. I. S. Zagon, J. W. Sassani, Y. Wu, and P. J. McLaughlin, “The autocrine derivation of the opioid growth factor, [Met5]-enkephalin, in ocular surface epithelium,” Brain Research, vol. 792, no. 1, pp. 72–78, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. I. S. Zagon, P. J. McLaughlin, S. R. Goodman, and R. E. Rhodes, “Opioid receptors and endogenous opioids in diverse human and animal cancers,” Journal of the National Cancer Institute, vol. 79, no. 5, pp. 1059–1065, 1987. View at Google Scholar · View at Scopus
  4. I. S. Zagon and P. J. McLaughlin, “An opioid growth factor regulates the replication of microorganisms,” Life Sciences, vol. 50, no. 16, pp. 1179–1187, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. I. S. Zagon, J. W. Sassani, G. Allison, and P. J. McLaughlin, “Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (ζ) opioid receptor in vertebrate cornea,” Brain Research, vol. 671, no. 1, pp. 105–111, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. I. S. Zagon, J. W. Sassani, Y. Wu, and P. J. McLaughlin, “The autocrine derivation of the opioid growth factor, [Met5]- enkephalin, in ocular surface epithelium,” Brain Research, vol. 792, no. 1, pp. 72–78, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. I. S. Zagon, J. W. Sassani, and P. J. McLaughlin, “Opioid growth factor modulates corneal epithelial outgrowth in tissue culture,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 268, no. 4, part 2, pp. R942–R950, 1995. View at Google Scholar · View at Scopus
  8. I. S. Zagon, J. W. Sassani, E. R. Kane, and P. J. McLaughlin, “Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor,” Brain Research, vol. 759, no. 1, pp. 92–102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. I. S. Zagon, J. W. Sassani, and P. J. McLaughlin, “Re-epithelialization of the rabbit cornea is regulated by opioid growth factor,” Brain Research, vol. 803, no. 1-2, pp. 61–68, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. I. S. Zagon, J. W. Sassani, and P. J. McLaughlin, “Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors,” Brain Research, vol. 798, no. 1-2, pp. 254–260, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. I. S. Zagon, J. W. Sassani, and P. J. McLaughlin, “Cellular dynamics of corneal wound re-epithelialization in the rat. II. DNA synthesis of the ocular surface epithelium following wounding,” Brain Research, vol. 839, no. 2, pp. 243–252, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. I. S. Zagon, J. W. Sassani, M. F. Verderame, and P. J. McLaughlin, “Particle-mediated gene transfer of opioid growth factor receptor cDNA regulates cell proliferation of the corneal epithelium,” Cornea, vol. 24, no. 5, pp. 614–619, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. I. S. Zagon, J. W. Sassani, K. J. Malefyt, and P. J. McLaughlin, “Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA,” Archives of Ophthalmology, vol. 124, no. 11, pp. 1620–1624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. I. S. Zagon, J. W. Sassani, and P. J. McLaughlin, “Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone,” Cornea, vol. 25, no. 7, pp. 821–829, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. P. A. Sieving, Sharp rise in diabetic eye disease makes American Diabetes Month ever more important 2012, http://nih.gov/news/health/nov2012/nei-06.htm.
  16. American Diabetes Association, Statistics about Diabetes: Data from the National Diabetes Statics Report, 2014, http://www.diabetes.org/diabetes-basics/statistics/?loc=db-slabnav.
  17. H. Abdelkader, D. V. Patel, C. N. Mcghee, and R. G. Alany, “New therapeutic approaches in the treatment of diabetic keratopathy: a review,” Clinical and Experimental Ophthalmology, vol. 39, no. 3, pp. 259–270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Rosenberg, T. M. T. Tervo, I. J. Immonen, L. J. Muller, C. Gronhagen-Riska, and M. H. Vesaluoma, “Corneal structure and sensitivity in type 1 diabetes mellitus,” Investigative Ophthalmology & Visual Science, vol. 41, no. 10, pp. 2915–2921, 2000. View at Google Scholar · View at Scopus
  19. M. Ozdemir, M. A. Buyukbese, A. Cetinkaya, and G. Ozdemir, “Risk factors for ocular surface disorders in patients with diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 59, no. 3, pp. 195–199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Cousen, P. Cackett, H. Bennett, K. Swa, and B. Dhillon, “Tear production and corneal sensitivity in diabetes,” Journal of Diabetes and Its Complications, vol. 21, no. 6, pp. 371–373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Dogru, C. Katakami, and M. Inoue, “Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus,” Ophthalmology, vol. 108, no. 3, pp. 586–592, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Neira-Zalentein, J. M. Holopainen, T. M. T. Tervo et al., “Corneal sensitivity in diabetic patients subjected to retinal laser photocoagulation,” Investigative Ophthalmology and Visual Science, vol. 52, no. 8, pp. 6043–6049, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Kaiserman, N. Kaiserman, S. Nakar, and S. Vinker, “Dry eye in diabetic patients,” American Journal of Ophthalmology, vol. 139, no. 3, pp. 498–503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. F. H. Grus, P. Sabuncuo, H. B. Dick, A. J. Augustin, and N. Pfeiffer, “Changes in the tear proteins of diabetic patients,” BMC Ophthalmology, vol. 2, no. 1, article 4, pp. 1–7, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Fallucca, G. Tonnarini, N. Di Biase, M. D'Allessandro, and M. Negri, “Plasma met-enkephalin levels in diabetic patients: influence of autonomic neuropathy,” Metabolism: Clinical and Experimental, vol. 45, no. 9, pp. 1065–1068, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Negri, G. Tonnarini, M. D'Alessandro, and F. Fallucca, “Plasma met-enkephalin in type I diabetes,” Metabolism, vol. 41, no. 5, pp. 460–461, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Negri, F. Fallucca, G. Tonnarini, P. Mariani, M. D'alessandro, and A. Pachí, “High levels of circulating met-enkephalin in pregnant and menstruating type 1 diabetic women,” Gynecological Endocrinology, vol. 4, no. 1, pp. 25–31, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Greenberg, F. Ellyin, G. Pullen, S. Ehrenpreis, S. P. Singh, and J. Cheng, “Methionine-enkephalin and β-endorphin levels in brain, pancreas, and adrenals of db/db mice,” Endocrinology, vol. 116, no. 1, pp. 328–331, 1985. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Timmers, N. R. Voyles, C. Zalenski, S. Wilkins, and L. Recant, “Altered β-endorphin, Met- and Leu- enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome,” Diabetes, vol. 35, no. 10, pp. 1143–1151, 1986. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Timmers, N. R. Voyles, S. Wilkins, O. E. Michaelis IV, S. J. Bhathena, and L. Recant, “Immunoreactive beta-endorphin and met- and leu-enkephalin contents in pancreas and pituitary of corpulent (cp/cp) rats,” International Journal of Obesity, vol. 13, no. 3, pp. 337–345, 1989. View at Google Scholar · View at Scopus
  31. I. S. Zagon, J. B. Jenkins, J. W. Sassani et al., “Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat,” Diabetes, vol. 51, no. 10, pp. 3055–3062, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. G. A. Lutty, “Effects of diabetes on the eye,” Investigative Ophthalmology and Visual Science, vol. 54, no. 14, pp. ORSF81–ORSF87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Bikbova, T. Oshitari, A. Tawada, and S. Yamamoto, “Corneal changes in diabetes mellitus,” Current Diabetes Reviews, vol. 8, no. 4, pp. 294–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. E. Plummer, A. Specht, and K. N. Gelatt, “Ocular manifestations of endocrine disease,” Compendium: Continuing Education For Veterinarians, vol. 29, no. 12, pp. 733–743, 2007. View at Google Scholar · View at Scopus
  35. S. Ramamurthi, M. Q. Rahman, G. N. Dutton, and K. Ramaesh, “Pathogenesis, clinical features and management of recurrent corneal erosions,” Eye, vol. 20, no. 6, pp. 635–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Ono, K. Yuki, N. Ozeki, D. Shiba, and K. Tsubota, “Ocular surface complications after trabeculectomy: incidence, risk factors, time course and prognosis,” Ophthalmologica, vol. 230, no. 2, pp. 93–99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Muñoz-Gutierrez, J. Alvarez De Toledo, R. I. Barraquer et al., “Post-surgical visual outcome and complications in Boston type 1 keratoprosthesis,” Archivos de la Sociedad Española de Oftalmología, vol. 88, no. 2, pp. 56–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Ivancic, Z. Mandic, J. Barac, and M. Kopic, “Cataract surgery and postoperative complications in diabetic patients,” Collegium Antropologicum, vol. 29, supplement 1, pp. 55–58, 2005. View at Google Scholar
  39. F. S. Brightbill, F. L. Myers, and G. H. Bresnick, “Postvitrectomy keratopathy,” American Journal of Ophthalmology, vol. 85, no. 5, part 1, pp. 651–655, 1978. View at Publisher · View at Google Scholar · View at Scopus
  40. I. S. Zagon, J. W. Sassani, and P. J. McLaughlin, “Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats,” Diabetes, vol. 55, no. 4, pp. 1141–1147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. I. S. Zagon, M. S. Klocek, J. W. Sassani, and P. J. McLaughlin, “Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus,” Archives of Ophthalmology, vol. 125, no. 8, pp. 1082–1088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. I. S. Zagon, M. S. Klocek, J. W. Sassani, D. T. Mauger, and P. J. McLaughlin, “Corneal safety of topically applied naltrexone,” Journal of Ocular Pharmacology and Therapeutics, vol. 22, no. 5, pp. 377–387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. S. Klocek, J. W. Sassani, P. J. McLaughlin, and I. S. Zagon, “Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats,” Experimental Eye Research, vol. 89, no. 5, pp. 686–692, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Klocek, J. W. Sassani, P. J. McLaughlin, and I. S. Zagon, “Topically applied naltrexone restores corneal reepithelialization in diabetic rats,” Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 2, pp. 89–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. I. S. Zagon, J. W. Sassani, J. A. Immonen, and P. J. Mclaughlin, “Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone,” Clinical and Experimental Ophthalmology, vol. 42, no. 2, pp. 159–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. I. N. Petropoulos, U. Alam, H. Fadavi et al., “Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy,” Investigative Ophthalmology & Visual Science, vol. 55, no. 4, pp. 2071–2078, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Tavakoli, C. Quattrini, C. Abbott et al., “Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy,” Diabetes Care, vol. 33, no. 8, pp. 1792–1797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Tavakoli, P. Kallinikos, A. Iqbal et al., “Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy,” Diabetic Medicine, vol. 28, no. 10, pp. 1261–1267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Tavakoli, A. J. M. Boulton, N. Efron, and R. A. Malik, “Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy,” Contact Lens and Anterior Eye, vol. 34, no. 1, pp. 7–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Tavakoli, I. N. Petropoulos, and R. A. Malik, “Assessing corneal nerve structure and function in diabetic neuropathy,” Clinical and Experimental Optometry, vol. 95, no. 3, pp. 338–347, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Tavakoli, I. N. Petropoulos, and R. A. Malik, “Corneal confocal microscopy to assess diabetic neuropathy: an eye on the foot,” Journal of Diabetes Science and Technology, vol. 7, no. 5, pp. 1179–1189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Papanas and D. Ziegler, “Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy,” Current Diabetes Reports, vol. 13, no. 4, pp. 488–499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Pritchard, K. Edwards, D. Vagenas, A. W. Russell, R. A. Malik, and N. Efron, “Corneal sensitivity is related to established measures of diabetic peripheral neuropathy,” Clinical and Experimental Optometry, vol. 95, no. 3, pp. 355–361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Pritchard, K. Edwards, A. M. Shahidi et al., “Corneal markers of diabetic neuropathy,” Ocular Surface, vol. 9, no. 1, pp. 17–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. F. Wang, N. Gao, J. Yin, and F.-S. X. Yu, “Reduced innervation and delayed re-innervation after epithelial wounding in type 2 diabetic Goto-Kakizaki rats,” The American Journal of Pathology, vol. 181, no. 6, pp. 2058–2066, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. E. P. Davidson, L. J. Coppey, R. H. Kardon, and M. A. Yorek, “Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 55, no. 3, pp. 1222–1230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Tavakoli, M. Mitu-Pretorian, I. N. Petropoulos et al., “Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation,” Diabetes, vol. 62, no. 1, pp. 254–260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. E. P. Davidson, L. J. Coppey, and M. A. Yorek, “Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment,” Investigative Ophthalmology and Visual Science, vol. 53, no. 13, pp. 8067–8074, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. I. S. Zagon, M. S. Klocek, J. W. Sassani, and P. J. McLaughlin, “Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus,” Archives of Ophthalmology, vol. 127, no. 11, pp. 1468–1473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. M. D. C. Alves, J. B. Carvalheira, C. M. Módulo, and E. M. Rocha, “Tear film and ocular surface changes in diabetes mellitus,” Arquivos Brasileiros de Oftalmologia, vol. 71, supplement 6, pp. 96–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Lv, A. Li, X. Zhang et al., “Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients,” Acta Ophthalmologica, vol. 92, no. 2, pp. e96–e104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. I. S. Zagon, A. M. Campbell, J. W. Sassani, and P. J. McLaughlin, “Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways,” Investigative Ophthalmology & Visual Science, vol. 53, no. 6, pp. 3234–3240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Yazdanpanah, M. Nasiri, and S. Adarvishi, “Literature review on the management of diabetic foot ulcer,” World Journal of Diabetes, vol. 6, no. 1, pp. 37–53, 2015. View at Publisher · View at Google Scholar
  64. P. J. McLaughlin, C. A. Pothering, J. A. Immonen, and I. S. Zagon, “Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats,” Experimental Biology and Medicine, vol. 236, no. 10, pp. 1122–1132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. P. J. McLaughlin, J. A. Immonen, and I. S. Zagon, “Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis,” Experimental Biology and Medicine, vol. 238, no. 7, pp. 733–743, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. Immonen, I. S. Zagon, G. S. Lewis, and P. J. McLaughlin, “Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats,” Experimental Biology and Medicine, vol. 238, no. 10, pp. 1127–1135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. J. A. Immonen, I. S. Zagon, and P. J. McLaughlin, “Topical naltrexone as treatment for type 2 diabetic cutaneous wounds,” Advances in Wound Care, vol. 3, no. 6, pp. 419–427, 2014. View at Publisher · View at Google Scholar
  68. D. Liang, J. W. Sassani, P. J. McLaughlin, and I. S. Zagon, “Topical application of naltrexone to the ocular surface of healthy volunteers: a tolerability study,” Journal of Ocular Pharmacology and Therapeutics, vol. 32, no. 2, pp. 127–132, 2016. View at Publisher · View at Google Scholar